BNP Paribas Financial Markets’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,485
Closed -$256K 3611
2021
Q3
$256K Buy
1,485
+703
+90% +$121K ﹤0.01% 2382
2021
Q2
$98.1K Buy
782
+705
+916% +$88.5K ﹤0.01% 2459
2021
Q1
$10.4K Sell
77
-1,720
-96% -$233K ﹤0.01% 3256
2020
Q4
$230K Buy
1,797
+597
+50% +$76.4K ﹤0.01% 2186
2020
Q3
$135K Sell
1,200
-42,173
-97% -$4.75M ﹤0.01% 2348
2020
Q2
$4.13M Buy
43,373
+23,514
+118% +$2.24M 0.01% 808
2020
Q1
$1.78M Buy
19,859
+13,513
+213% +$1.21M ﹤0.01% 1126
2019
Q4
$336K Sell
6,346
-1,749
-22% -$92.7K ﹤0.01% 2074
2019
Q3
$320K Buy
8,095
+2,163
+36% +$85.5K ﹤0.01% 1871
2019
Q2
$244K Sell
5,932
-4,219
-42% -$173K ﹤0.01% 1896
2019
Q1
$473K Buy
10,151
+9,282
+1,068% +$432K ﹤0.01% 1600
2018
Q4
$37.8K Sell
869
-1,306
-60% -$56.9K ﹤0.01% 2183
2018
Q3
$124K Buy
2,175
+498
+30% +$28.5K ﹤0.01% 1983
2018
Q2
$81.4K Sell
1,677
-6,092
-78% -$296K ﹤0.01% 2259
2018
Q1
$304K Buy
7,769
+39
+0.5% +$1.53K ﹤0.01% 1994
2017
Q4
$328K Buy
7,730
+4,316
+126% +$183K ﹤0.01% 2088
2017
Q3
$127K Sell
3,414
-213
-6% -$7.95K ﹤0.01% 2315
2017
Q2
$110K Buy
3,627
+3,288
+970% +$99.9K ﹤0.01% 2364
2017
Q1
$8.97K Sell
339
-1,490
-81% -$39.4K ﹤0.01% 2661
2016
Q4
$46.7K Sell
1,829
-292
-14% -$7.45K ﹤0.01% 2417
2016
Q3
$76.8K Buy
2,121
+1,041
+96% +$37.7K ﹤0.01% 2230
2016
Q2
$36.7K Buy
+1,080
New +$36.7K ﹤0.01% 2398
2016
Q1
Sell
-4,298
Closed -$210K 3234
2015
Q4
$210K Sell
4,298
-263
-6% -$12.8K ﹤0.01% 1900
2015
Q3
$114K Buy
4,561
+2,637
+137% +$65.7K ﹤0.01% 2310
2015
Q2
$60.9K Buy
1,924
+1,532
+391% +$48.5K ﹤0.01% 2370
2015
Q1
$14.9K Buy
+392
New +$14.9K ﹤0.01% 2523
2014
Q4
Sell
-889
Closed -$26.9K 3006
2014
Q3
$26.9K Buy
+889
New +$26.9K ﹤0.01% 2507
2014
Q2
Sell
-7
Closed -$240 3489
2014
Q1
$240 Sell
7
-72
-91% -$2.47K ﹤0.01% 2733
2013
Q4
$3.13K Buy
+79
New +$3.13K ﹤0.01% 2892